Plant crude extracts containing oligomeric hemagglutinins protect chickens against highly Pathogenic Avian Influenza Virus after one dose of immunization

• Published in: Veterinary Research Communications
• Main Authors: Phan, Hoang Trong, Tran, Hanh Xuan, Ho, Thuong Thi, Pham, Van Thi, Trinh, Vy Thai, Nguyen, Tra Thi, Pham, Ngoc Bich, Chu, Ha Hoang, Conrad, Udo
• Language: English
• Published: 2022
• Subjects: Hemagglutinin oligomers; Challenge experiments; Avian flu; Plant-based vaccine
• Online Access: https://repository.publisso.de/resource/frl:6440179; https://doi.org/10.1007/s11259-022-09942-3; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145123/; https://link.springer.com/article/10.1007/s11259-022-09942-3#Sec23

Highly pathogenic avian influenza viruses (HPAIV) have been responsible for causing several severe outbreaks across the world. To protect poultry farms and to prevent the possible spread of new influenza pandemics, vaccines that are both efficacious and low-cost are in high demand. We produced stable, large hemagglutinin H5 oligomers in planta by the specific interaction between S*Tag and S*Protein. H5 oligomers combined via S*Tag::S*Protein interaction in plant crude extracts induced strong humoral immune responses, strong neutralizing antibody responses, and resistance in chickens after challenge with a wild type HPAIV H5 virus strain. In all three parameters, plant crude extracts with H5 oligomers induced better responses than crude extracts containing trimers. The neutralizing antibodies induced by by two-dose and one dose immunization with an adjuvanted crude extract containing H5 oligomer protected vaccinated chickens from two lethal H5N1 virus strains with the efficiency of 92% and 100%, respectively. Following housing vaccinated chickens together with ten non-immunized chickens, only one of these chickens had detectable levels of the H5N1 virus. To facilitate the easy storage of a candidate vaccine, the H5 oligomer crude extracts were mixed with adjuvants and stored for 3.5 and 5.5 months at 4 degrees C, and chickens were immunized with these crude extracts. All these vaccinated chickens survived after a lethal H5N1 virus challenge. H5 oligomer crude extracts are comparable to commercial vaccines as they also induce strong virus-neutralizing immune responses following the administration of a single dose. The cost-effective production of plant crude extract vaccine candidates and the high stability after long-term storage will enable and encourage the further exploration of this technology for veterinary vaccine development.